San Francisco, Nov. 23, 2015 (GLOBE NEWSWIRE) -- The global erectile dysfunction drugs market is expected to reach USD 3.2 billion by 2022 according to a new report by Grand View Research Inc. Rising adoption of sedentary lifestyle and increasing prevalence of conditions causing erectile dysfunction such as stress, hypertension, and related medications are the key factors expected to widen the target population base for this market.
However, the market is estimated to witness decline in revenue over the forecast period. Expiration of key drugs from 2017 to 2019 is likely to curb revenue growth. On the other hand, the market is likely to open up new avenues for the generic manufacturers to capitalize on. The increasing risk of sexually transmitted diseases, narrowing of insurance coverage for erectile dysfunction treatment, growing threat from counterfeit drugs, and presence of social stigma in developing countries are some factors limiting penetration rates.
Browse to access In-depth research report on Global Erectile Dysfunction Drugs Market with detailed charts and figures: http://www.grandviewresearch.com/industry-analysis/erectile-dysfunction-drugs-market
Further key findings from the report suggest:
Request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/erectile-dysfunction-drugs-market/request
Grand View Research has segmented the global erectile dysfunction drugs market on the basis of product and region:
Erectile Dysfunction Drugs Product Outlook (Revenue, USD Million, 2012 – 2022)
Erectile Dysfunction Drugs Regional Outlook (Revenue, USD Million, 2012 – 2022)
Browse related reports by Grand View Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Corporate Sales Specialist, USA
Grand View Research, Inc
Toll Free: 1-888-202-9519